Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis

BACKGROUND: Although the clinical benefit of obtaining a remission in proteinuria in nephrotic patients with focal segmental glomerulosclerosis (FSGS) is recognized, the long-term value of maintaining it and the impact of relapses on outcome are not well described. METHODS: We examined the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jauhal, Arenn, Reich, Heather N, Hladunewich, Michelle, Barua, Moumita, Hansen, Bettina E, Naimark, David, Troyanov, Stéphan, Cattran, Daniel C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064837/
https://www.ncbi.nlm.nih.gov/pubmed/35948275
http://dx.doi.org/10.1093/ndt/gfac238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064837/
https://www.ncbi.nlm.nih.gov/pubmed/35948275
http://dx.doi.org/10.1093/ndt/gfac238

Ejemplares similares